A drug used to treat breast cancer, neratinib, has the potential to stop the immune system from destroying beta cells in type 1 diabetes, according to German researchers. The researchers found that Neratinib was able to protect the beta cells, which produce insulin in the pancreas, enabling the beta cells to continue to produce insulin. Read more